RedChip Companies
|
Weekly Newsletter
|
|
BioVie Presents Rationale for Potentially Pivotal Trial of NE3107 in the Treatment of Parkinson’s Disease at 2023 International Association of Parkinsonism and Related Disorders World Congress
|
BioVie (Nasdaq: BIVI), a clinical-stage company developing innovative drug therapies for the treatment of neurological and neurodegenerative disorders and advanced liver disease, announced that a poster detailing the supporting data and rationale for a potentially pivotal clinical trial of NE3107 in the treatment of Parkison’s Disease was presented at the 2023 World Congress on Parkison’s Disease and Related Disorders (IAPRD), held in Chicago, IL May 13-16, 2023.
For more information, visit www.bioviepharma.com
|
Reviv3 Procare Subsidiary Signs Multi-Year Licensing Agreement with NASCAR
Reviv3 Procare (OTCQB: RVIV) wholly owned subsidiary Reeviv3 Acquisition Corp. entered into a multi-year licensing agreement with NASCAR. Under the terms of the agreement, Reviv3 will produce and sell a new line of NASCAR-branded earbuds, earmuffs, hearing devices, ear plugs, and outdoor speakers in NASCAR venues and distribution channels in the US, Puerto Rico, and Canada, as well as at US military bases around the world.
|
KWESST Provides Update on CFO Replacement, Defence Contracts in Progress, Upcoming Participation at CANSEC, and Confirms Filing of Q2 Financials
KWESST Micro Systems (Nasdaq: KWE) updated shareholders on its search for a permanent CFO, the potential increase in scope and value of two of its defense contracts, it's participation at the annual Canadian defence show in Ottawa, and confirmed filing of its financial results for Q2 of Fiscal 2023.
|
|
|
Soligenix Announces European Patent Grant for Use of Dusquetide in Oral Mucositis
Soligenix (Nasdaq: SNGX), a late-stage biopharmaceutical company focused on developing and commercializing products to treat rare diseases where there is an unmet medical need, announced that the European Patent Office has granted a patent entitled "Novel Peptides and Analogs for Use in the Treatment of Oral Mucositis". This granted patent builds on similar intellectual property issued in the United States (U.S.), New Zealand, Japan, Australia and Singapore, as well as many pending patent applications in other jurisdictions worldwide. The granted claims will cover therapeutic uses of dusquetide (active ingredient in SGX942) and related innate defense regulator (IDR) analogs, and adds to composition of matter claims for dusquetide and related analogs that have been issued in the U.S. and worldwide.
|
Genius Group Shareholders Approve Spin Off of Entrepreneur Resorts Limited and New Constitution
Genius Group (NYSE American: GNS), a leading entrepreneur edtech and education group, held an Extraordinary General Meeting on May 16, 2023, approving the adoption of a new constitution and spin off of Entrepreneur Resorts Limited to shareholders. Roger Hamilton, CEO of Genius Group, said, “The Board thanks Genius Group’s shareholders for passing those two resolutions which will enable Genius Group and Entrepreneur Resorts Limited’s management teams to streamline operations and focus on their respective business models more effectively.”
|
|
|
Upcoming Events |
|
|
|
NASDAQ: SNGX - Soligenix |
4:15pm Eastern |
Soligenix Inc is a late-stage biopharmaceutical company based in the United States. It focuses on developing and commercializing products to treat rare diseases where there is an unmet medical need. |
|
|
|
|
NASDAQ: LTRN - Lantern Pharma |
4:15pm Eastern |
Lantern Pharma is a clinical stage oncology-focused company who is harnessing the power of Artificial Intelligence and Genomics to develop precision cancer therapies. |
|
|
|
|
NYSE American: GNS - Genius Group |
11:00am Eastern |
Genius Group is a world leading entrepreneur Edtech and education group, with a mission to disrupt the current education model with a student-centered, life-long learning curriculum that prepares students with the leadership, entrepreneurial and life skills to succeed in today’s market. |
|
|
|
|
NASDAQ: STSS - Sharps Technology |
4:15pm Eastern |
Sharps Technology is a medical device and pharmaceutical packaging company specializing in the development and manufacturing of innovative drug delivery systems. |
|
|
|
|
NASDAQ: ALAR - Alarum Technologies |
11:00am Eastern |
Alarum Technologies Ltd. is an Israel-based company engaged in the information security business. It controls and secures data exchange, preventing data exfiltration, leakage, malware, ransomware, and fraud. |
|
|
|
|
NASDAQ: BFRG - BullFrog AI |
4:15pm Eastern |
BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
4:15pm Eastern |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
Archive Events |
|
|
|
NASDAQ: BIVI - BioVie |
Meeting Duration 43 minutes |
BioVie Inc. (NASDAQ: BIVI) is a clinical-stage company developing what it believes will be transformative therapies to overcome unmet medical needs in neurodegeneration and liver disease. |
|
|
|
|
NASDAQ: BFRG - BullFrog AI |
Meeting Duration 35 minutes |
BullFrog AI is a digital technology company using machine learning to usher in a new era of precision medicine. |
|
|
|
|
NASDAQ: UNCY - Unicycive Therapeutics |
Meeting Duration 28 minutes |
Unicycive Therapeutics Inc is a biotechnology company dedicated to developing treatments for certain medical conditions. |
|
|
|
|
NASDAQ: ASPI - ASP Isotopes |
Meeting Duration 32 minutes |
ASP Isotopes Inc is a pre-commercial stage advanced materials company dedicated to the development of technology and processes that, if successful, will allow for the production of isotopes that may be used in several industries. |
|
|
|
|
NASDAQ: GENE - Genetic Technologies Limited |
Meeting Duration 30 minutes |
Genetic Technologies Limited is a diversified molecular diagnostics company developing tools for the prediction and assessment of chronic disease risk to help physicians proactively manage patient health. |
|
|
|
|
NASDAQ: IINN - Inspira Technologies |
Meeting Duration 38 minutes |
Inspira Technologies Oxy BHN Ltd is a specialty medical device company engaged in the research, development, manufacture, and marketing of proprietary respiratory support technology that is intended to provide an alternative to invasive mechanical ventilation (MV), which is the standard of care today for the treatment of respiratory failure. |
|
|
|
|
NASDAQ: ALAR - Alarum Technologies |
Meeting Duration 37 minutes |
Alarum Technologies Ltd. is an Israel-based company engaged in the information security business. It controls and secures data exchange, preventing data exfiltration, leakage, malware, ransomware, and fraud. |
|
|
|
|
NASDAQ: RVSN - Rail Vision |
Meeting Duration 44 minutes |
Rail Vision is the leading provider of obstacle detection and classification systems in the railway industry. |
|
|
|
|
NASDAQ: ARDS - Aridis Pharmaceuticals |
Meeting Duration 40 minutes |
Aridis Pharmaceuticals, Inc. discovers and develops novel anti-infective therapies to treat life-threatening infections, including anti-infectives to be used as add-on treatments to standard-of-care antibiotics. |
|
|
|
|
NASDAQ: DGLY - Digital Ally |
Meeting Duration 31 minutes |
Digital Ally Companies is a diversified holding company with operations in video solution technology, human and animal health protection products, healthcare revenue cycle management, ticket brokering and marketing, and event production. |
|
|
Lesson of the Week
Management is the first fundamental to consider when evaluating smaller-cap companies.
|
|
|
MidSouth Week in Review
The inflation rate came out at 4.9%, the lowest rate since April 2021.
|
|
|
You are receiving this email because your email is subscribed to our mailing list.
Click here to update your subscription or unsubscribe your email address.
Copyright © 2023. All rights reserved.
|
© 2023 RedChip , All rights reserved
|
|
|
|
|